Notable Put Options Activity in Keryx Biopharmaceuticals
Shares of Keryx Biopharmaceuticals (NASDAQ: KERX) are higher on the session by 2.96%, currently trading at $2.78. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average.
Options traders are focusing on puts today. The strike seeing the heaviest action is the January 2012 $2.50 put, which has traded 1,500 times on open interest of 14,928 contracts.
Put volume is outpacing call volume by 2 to 1.
Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.